William Febbo | Chief Executive Officer |
Doug Baker | Chief Financial Officer |
Stephen Silvestro | Chief Commercial Officer |
Miriam Paramore | President |
Ryan Daniels | William Blair |
Andrew D'Silva | B. Riley FBR |
Eric Martinuzzi | Lake Street |
Richard Baldry | ROTH Capital |
Alex Silverman | AWM Investments |
Josh Goldberg | G2 Investment Partners |
Good afternoon, and thank you for joining us today to discuss OptimizeRx Corporation's Second Quarter ended June 30, 2020. With us today are the Company's Chief Executive Officer, William Febbo; Company President, Miriam Paramore; Chief Financial Officer, Doug Baker; and Chief Commercial Officer, Stephen Silvestro.
Following management's remarks today, we'll open the call to questions. And before we conclude today's call, I'll provide some important cautions regarding the forward-looking statements made by management during the call. I'd like to remind everyone that today's call is being recorded and will be made available for telephone replay via instructions on today's press release in the Investors section of the company's website.